Thanks to a new technology, the diagnosis of brain cancer undergoes a breakthrough. The credit goes to cancer diagnostics company and University of Strathclyde Dxcover spin-out company. The company has indeed launched the liquid biopsy Dxcover, which was also effective in the early days of cancer growth, at a smaller volume and earlier stage.
q
There Research was published in the scientific journal Cancers.
Brain cancer: here are the advantages of the Dxcover liquid biopsy
According to Cancer Research UK, a 12,000 people in Britain are diagnosed with brain cancer each year and survival rates are 12% five years after diagnosis.
Read Also
- Surprisingly, Huawei exceeds Samsung and become the number 1 in the world market of smartphones Jul 30, 2020
- Nice: Christian Estrosi welcomes the decision of the Marseille court on the destruction of the TNN Nov 17, 2022
- Riverdale 5 episode 15 Spanish Latin online free: channel, time and when to see the new premiere episode Sep 7, 2021
- ASLAN2021 HYBRID: the countdown begins | News | Infrastructures May 31, 2021
- Temptation Island: Tommaso Eletti justifies himself with Volpe and Bruganelli Sep 8, 2021
- Google, we change: here is the core update of July, what happens Jul 9, 2021
- Elon Musk said a recession in the United States would be “a good thing” and predicted how long it could last May 27, 2022